...
首页> 外文期刊>The Journal of Nuclear Medicine >Redifferentiation therapy with retinoic acid in follicular thyroid cancer.
【24h】

Redifferentiation therapy with retinoic acid in follicular thyroid cancer.

机译:维甲酸用于甲状腺滤泡癌的再分化治疗。

获取原文
获取原文并翻译 | 示例
           

摘要

We report on a patient with a follicular Hurthle cell carcinoma in whom distant metastases were initially radioiodine negative or only weakly positive. Redifferentiation therapy with 13-cis retinoic acid induced a significant radioiodine uptake in metastatic tissue. Thyroglobulin (Tg) immunostaining and autoradiography of a bone metastasis in the right femur, which was initially radioiodine negative, proved Tg synthesis, combined with iodine incorporation into tumor cells. Glucose metabolism in metastases was partially increased and partially unchanged after redifferentiation therapy. The distinct increase of serum Tg after retinoic acid treatment was interpreted as a functional sign of redifferentiation.
机译:我们报告了一个滤泡性hurthle细胞癌患者,其中远处转移最初是放射性碘阴性或仅是弱阳性。 13-顺式视黄酸的再分化疗法在转移组织中引起大量的放射性碘吸收。甲状腺球蛋白(Tg)的免疫染色和放射自显影对右股骨的骨转移(最初是放射性碘阴性)进行了Tg合成,并与碘掺入肿瘤细胞结合。重新分化治疗后,转移中的葡萄糖代谢部分增加,部分不变。维甲酸处理后血清Tg的明显增加被认为是再分化的功能性标志。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号